The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis

[1]  M. Sherman,et al.  Screening for hepatocellular carcinoma , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[2]  O. Arrieta,et al.  Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[3]  D. Kershenobich,et al.  Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus‐related liver cirrhosis , 2006, Cancer.

[4]  M. Zoli,et al.  Diagnostic and Prognostic Role of α-Fetoprotein in Hepatocellular Carcinoma: Both or Neither? , 2006, The American Journal of Gastroenterology.

[5]  J. Sung,et al.  An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. Carithers,et al.  Practice Guidelines : Evaluation of the Patient for Liver Transplantation , 2005 .

[7]  G. Gores,et al.  Diagnosis and staging of hepatocellular carcinoma. , 2004, Gastroenterology.

[8]  T. Chen,et al.  Does Screening or Surveillance for Primary Hepatocellular Carcinoma with Ultrasonography Improve the Prognosis of Patients? , 2004, Cancer journal.

[9]  G. Mizejewski.  Levels of Alpha-Fetoprotein During Pregnancy and Early Infancy in Normal and Disease States , 2003, Obstetrical & gynecological survey.

[10]  M. Yuen,et al.  Screening for hepatocellular carcinoma: survival benefit and cost-effectiveness. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  C. Ricós,et al.  Reference change value for alpha-fetoprotein and its application in early detection of hepatocellular carcinoma in patients with hepatic disease. , 2003, Clinical chemistry.

[12]  Samir Gupta,et al.  Test Characteristics of -Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C , 2003, Annals of Internal Medicine.

[13]  H. El‐Serag.  Hepatocellular carcinoma: an epidemiologic view. , 2002, Journal of clinical gastroenterology.

[14]  E. Bass,et al.  Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic review , 2002, Hepatology.

[15]  M. Tong,et al.  Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America , 2001, Journal of gastroenterology and hepatology.

[16]  M. Bernardi,et al.  Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. , 2001, Journal of hepatology.

[17]  M. Sherman,et al.  Alphafetoprotein: an obituary. , 2001, Journal of hepatology.

[18]  M. Sherman,et al.  Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis , 2001, Gut.

[19]  Y. Patt,et al.  Nonsurgical treatment of hepatocellular carcinoma. , 2001, Clinics in liver disease.

[20]  P. Tangkijvanich,et al.  Clinical Characteristics and Prognosis of Hepatocellular Carcinoma: Analysis Based on Serum Alpha-fetoprotein Levels , 2000, Journal of clinical gastroenterology.

[21]  M. Pompili,et al.  Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients. , 2000, Hepato-gastroenterology.

[22]  C. Cs,et al.  The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma. , 1999 .

[23]  M. Sherman,et al.  Screening for hepatocellular carcinoma , 1998, Hepatology.

[24]  F. Sarasin,et al.  Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. , 1996, The American journal of medicine.

[25]  G. Budillon,et al.  Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato. , 1996, Journal of hepatology.

[26]  Kenzo Kobayashi,et al.  Prospective study of α‐fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma , 1994 .

[27]  K. Tanikawa,et al.  Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis. , 1993, Hepato-gastroenterology.

[28]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[29]  A. Nonomura,et al.  Alpha‐fetoprotein production by hepatocellular carcinoma is prognostic of poor patients survival , 1992, Journal of surgical oncology.

[30]  M. Colombo,et al.  Hepatocellular carcinoma in Italian patients with cirrhosis. , 1991, The New England journal of medicine.

[31]  Y. Chung,et al.  Specificities of serum α‐fetoprotein in HBsAg+ and HBsAg− patients in the diagnosis of hepatocellular carcinoma , 1991 .

[32]  E. Schiff,et al.  Hepatitis C–associated hepatocellular carcinoma , 1990, Hepatology.

[33]  L. Bolondi,et al.  Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population. , 1990, The Italian journal of gastroenterology.

[34]  J. Hoofnagle,et al.  Elevations in serum alpha‐fetoprotein levels in patients with chronic hepatitis B , 1989, Cancer.

[35]  K. Ohnishi,et al.  Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha‐fetoprotein levels. Analysis of 606 patients , 1989, Cancer.

[36]  B. McMahon,et al.  Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virus. , 1985, JAMA.

[37]  B. Portmann,et al.  RISK FACTORS IN DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CIRRHOSIS: PROSPECTIVE STUDY OF 613 PATIENTS , 1985, The Lancet.

[38]  E. Christensen,et al.  Prognostic Value of Child‐Turcotte Criteria in Medically Treated Cirrhosis , 1984, Hepatology.

[39]  K. Shigeta,et al.  Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study. , 1980, Hepato-gastroenterology.

[40]  M. Kew,et al.  Alpha-fetoprotein in primary liver cancer and other diseases. , 1974, Gut.

[41]  M. Ionescu,et al.  Long‐term results of surgical treatment for bleeding oesophageal varices in children with portal hypertension , 1973, The British journal of surgery.

[42]  R. Molinari,et al.  Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease. , 2001, European journal of cancer.

[43]  C. Chan,et al.  The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma. , 1999, Hepato-gastroenterology.

[44]  F. Trevisani,et al.  Etiologic factors and clinical presentation of hepatocellular carcinoma: Differences between cirrhotic and noncirrhotic Italian patients , 1995, Cancer.

[45]  I. Sartori.  Early Recognition of Hepatocellular Carcinoma Based on Altered Profiles of Alpha-Fetoprotein: , 1994 .

[46]  D. Pateron,et al.  Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. , 1994, Journal of hepatology.

[47]  A. Reid,et al.  The search for the ultimate screening test for hepatocellular carcinoma continues. , 1994, Hepatology.